Missed gall bladder malignancy: A result of ignoring predisposing factors

  • Отримано 09.08.2023
  • Доопрацьовано 23.10.2023
  • Прийнято 28.11.2023
  • 965 Переглядів
  • Взято з Vol. 9, No. 2, 2023
  • Сторінки 6-14

The underestimation of the prevalence of gallbladder carcinoma, which constitutes a predominant form of malignant neoplasm affecting the biliary tract, poses a significant threat due to its asymptomatic progression. Therefore, this study aimed to analyse the clinical, imaging, and intraoperative outcomes in cases of gallbladder carcinoma. This retrospective investigation was conducted from September 2022 to March 2023 at the Department of General Surgery of FH Medical College. A total of 153 patients deemed suitable for surgery participated in this study and underwent the relevant procedures. Various diagnostic and laboratory tests were administered to the patients, including blood analysis, random blood sugar determination, viral markers, chest X-ray, renal and hepatic functional tests, and comprehensive abdominal ultrasound. Gallbladder specimens were subjected to histopathological examination, and the results were documented and analysed. In histopathological reports, signs of precancerous lesions were noted in 30 out of 153 patients who underwent surgical treatment. The frequency of the disease was higher among women. Among these 30 patients, 22 had ultrasound-diagnosed gallstone disease with acute or chronic cholecystitis, while 8 patients had gallstone disease without gallbladder wall thickening. Additionally, 9 of these patients exhibited focal/irregular/thickening of the wall ≥10 mm. Overall, 16 patients showed elevated liver function, and 4 had an increased glucose level among those with histopathological evidence of precancerous lesions. This study underscores the elusive nature of gallbladder cancer, emphasizing the necessity for a comprehensive assessment, meticulous preoperative evaluation, and a multidisciplinary approach to facilitate early detection and treatment

laparoscopic cholecystectomy; gallbladder carcinoma; histopathological examination; computed tomography scan

https://doi.org/10.61751/ijmmr/2.2023.06

[1] Di Mauro D, Orabi A, Myintmo A, Reece-Smith A, Wajed S, Manzelli A. Routine examination of gallbladder specimens after cholecystectomy: A single-centre analysis of the incidence, clinical and histopathological aspects of incidental gallbladder carcinoma. Discov Oncol. 2021;12(1):e4. DOI: 10.1007/s12672-021-00399-5

[2] Jha V, Sharma P, Mandal KA. Incidental gallbladder carcinoma: Utility of histopathological evaluation of routine cholecystectomy specimens. South Asian J Cancer. 2018;7(1):21–23. DOI: 10.4103/2278-330X.226802

[3] Lundgren L, Muszynska C, Ros A, Persson G, Gimm O, Valter L, et al. Are incidental gallbladder cancers missed with a selective approach of gallbladder histology at cholecystectomy? World J Surg. 2018;42(4):1092–99. DOI: 10.1007/s00268-017-4215-0

[4] Roa JC, Basturk O, Adsay V. Dysplasia and carcinoma of the gallbladder: Pathological evaluation, sampling, differential diagnosis and clinical implications. Histopathology. 2021;79(1):2–19. DOI: 10.1111/his.14360

[5] Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93–2. DOI: 10.5114/ceh.2019.85166

[6] Roa JC, García P, Kapoor VK, Maithel SK, Javle M, Koshiol J. Gallbladder cancer. Nat Rev Dis Primers. 2022;8(1):e69. DOI: 10.1038/s41572-022-00398-y

[7] Gupta V, Chandra A, Gupta V, Patel R, Dangi A, Pai A. Gallbladder perforation: A single-center experience in north India and a step-up approach for management. Hepatobiliary Pancreat Dis Int. 2022;21(2):168–74. DOI: 10.1016/j.hbpd.2021.08.011

[8] Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8(4):e33. DOI: 10.21037/cco.2019.08.03

[9] Kalra N, Gupta P, Singhal M, Gupta R, Gupta V, Srinivasan R, et al. Cross-sectional imaging of gallbladder carcinoma: An update. J Clin Exp Hepatol. 2019;9(3):334–44. DOI: 10.1016/j.jceh.2018.04.005

[10] Vuthaluru S, Sharma P, Chowdhury S, Are C. Global epidemiological trends and variations in the burden of gallbladder cancer. J Surg Oncol. 2023;128(6):980–88. DOI: 10.1002/jso.27450

[11] The World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [Internet]. Available from: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/

[12] Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al., editors. AJCC Cancer Staging Manual [Internet]. 8th ed. Cham: Springer; 2017 [cited 2023 Dec 27]. 1032 p. Available from: https://link.springer.com/book/9783319406176

[13] Rather MH, Malik NA, Gilkar IA, Jeelani S, Mushtaq U, Peer JA, et al. Clinical study of incidental Gall bladder malignancy after elective cholecystectomy. A retrospective study. J Evid Based Med Healthc. 2019;6(14):1145–49. DOI: 10.18410/jebmh/2019/239

[14] Singh N, Zaidi A, Kaur R, Kaur J, Nijhawan VS. Incidental gallbladder neoplasms: A growing global burden. Cureus. 2022;14(6):e25805. DOI: 10.7759/cureus.25805

[15] Poudel R, Shah A. Incidence of incidental gall bladder cancer and role of routine histopathological examination in cholecystectomies specimens for benign disease. J Nepal Health Res Counc. 2020;18(3):547–50. DOI: 10.33314/jnhrc.v18i3.1974

[16] Halaseh SA, Halaseh S, Shakman R. A review of the etiology and epidemiology of gallbladder cancer: What you need to know. Cureus. 2022;14(8):e28260. DOI: 10.7759/cureus.28260

[17] Zu Y, Yang J, Zhang C, Liu D. The pathological mechanisms of Oestrogen-induced cholestasis: Current perspectives. Front Pharmacol. 2021;12:761255. DOI: 10.3389/fphar.2021.761255

[18] Valle JW, Kelley K, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428–44. DOI: 10.1016/S0140-6736(21)00153-7

[19] Bastiaenen VP, Tuijp JE, van Dieren S, Besselink MG, van Gulik TM, Koens L, et al. Safe, selective histopathological examination of gallbladder specimens: A systematic review. Br J Surg. 2020;107(11):1414–28. DOI: 10.1002/bjs.11759

[20] Corten BJGA, Alexander S, van Zwam PH, Leclercq WKG, Roumen RMH, Slooter GD. Outcome of surgical inspection of the gallbladder in relation to final pathology. J Gastrointest Surg. 2019;23(6):1130–34. DOI: 10.1007/s11605-018-3921-8

[21] Geramizadeh B, Kashkooe A. Incidental gall bladder adenocarcinoma in cholecystectomy specimens; a single center experience and review of the literature. Middle East J Dig Dis. 2018;10(4):249–53. DOI: 10.15171/mejdd.2018.118